Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Bibliographic Details
Main Authors: Frey, Reiner, Mück, Wolfgang, Kirschbaum, Nina, Krätzschmar, Jörn, Weimann, Gerrit, Wensing, Georg
Format: Online
Language:English
Published: BioMed Central 2009
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313325/
id pubmed-3313325
recordtype oai_dc
spelling pubmed-33133252012-03-28 Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521) Frey, Reiner Mück, Wolfgang Kirschbaum, Nina Krätzschmar, Jörn Weimann, Gerrit Wensing, Georg Poster Presentation BioMed Central 2009-08-11 /pmc/articles/PMC3313325/ http://dx.doi.org/10.1186/1471-2210-9-S1-P15 Text en Copyright ©2009 Frey et al; licensee BioMed Central Ltd.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Frey, Reiner
Mück, Wolfgang
Kirschbaum, Nina
Krätzschmar, Jörn
Weimann, Gerrit
Wensing, Georg
spellingShingle Frey, Reiner
Mück, Wolfgang
Kirschbaum, Nina
Krätzschmar, Jörn
Weimann, Gerrit
Wensing, Georg
Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
author_facet Frey, Reiner
Mück, Wolfgang
Kirschbaum, Nina
Krätzschmar, Jörn
Weimann, Gerrit
Wensing, Georg
author_sort Frey, Reiner
title Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_short Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_full Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_fullStr Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_full_unstemmed Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_sort warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (bay 63-2521)
description
publisher BioMed Central
publishDate 2009
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313325/
_version_ 1611516998842318848

Similar Items